Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers? - Archive ouverte HAL Access content directly
Journal Articles Cancers Year : 2020

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

(1) , (1) , (1) , (1) , (1)
1

Abstract

Osteosarcoma and Ewing sarcoma are the most prevalent bone pediatric tumors. Despite intensive basic and medical research studies to discover new therapeutics and to improve current treatments, almost 40% of osteosarcoma and Ewing sarcoma patients succumb to the disease. Patients with poor prognosis are related to either the presence of metastases at diagnosis or resistance to chemotherapy. Over the past ten years, considerable interest for the Hippo/YAP signaling pathway has taken place within the cancer research community. This signaling pathway operates at different steps of tumor progression: Primary tumor growth, angiogenesis, epithelial to mesenchymal transition, and metastatic dissemination. This review discusses the current knowledge about the involvement of the Hippo signaling pathway in cancer and specifically in paediatric bone sarcoma progression.
Fichier principal
Vignette du fichier
Publi4.pdf (2.07 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-03004096 , version 1 (13-11-2020)

Identifiers

Cite

Sarah Morice, Geoffroy Danieau, Françoise Rédini, Bénédicte Brounais-Le-Royer, Franck Verrecchia. Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?. Cancers, 2020, 12 (3), pp.645. ⟨10.3390/cancers12030645⟩. ⟨inserm-03004096⟩
16 View
84 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More